Mass spectrometry-based profiling can identify post-translational modifications such as phosphorylation, as demonstrated by tau hyperphosphorylation in AD organoids, which is a hallmark of altered signaling pathways (Bracha et al., 2024; Marinho et al., 2023). Here, MAPT is linked to Alzheimer disease.